DiaSorin SpA
ISIN IT0003492391
|WKN A0MTB2
Market cap (in EUR)
3,301 m
Country
Italy
Sector
Healthcare
Dividend yield
2.03%
Overview
Description
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices Italy
Financials
Key metrics
| Market capitalisation, EUR | 3,301 m |
| EPS, EUR | - |
| P/B ratio | 2.1 |
| P/E ratio | 22.0 |
| Dividend yield | 2.03% |
Income statement (2025)
| Revenue, EUR | 1,195 m |
| Net income, EUR | 150 m |
| Profit margin | 12.55% |
What ETF is DiaSorin SpA in?
There are 22 ETFs which contain DiaSorin SpA. All of these ETFs are listed in the table below. The ETF with the largest weighting of DiaSorin SpA is the Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.